Literature DB >> 14666027

N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: results of a randomized, double-blind, placebo-controlled clinical trial.

Paschalis Tossios1, Wilhelm Bloch, Astrid Huebner, M Reza Raji, Fotini Dodos, Oliver Klass, Michael Suedkamp, Stefan-Mario Kasper, Martin Hellmich, Uwe Mehlhorn.   

Abstract

OBJECTIVE: Reactive oxygen species have been shown to contribute to myocardial stress in patients undergoing cardiac surgery, as demonstrated by myocardial 8-iso-prostaglandin-F(2)alpha and nitrotyrosine formation. We hypothesized that the reactive oxygen species scavenger N-acetylcysteine attenuates reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery.
METHODS: Forty patients undergoing coronary artery surgery (mean age +/- SD, 66 +/- 9 years; 9 women and 31 men) were randomized to receive either N-acetylcysteine (100 mg/kg into cardiopulmonary bypass prime followed by infusion at 20 mg.kg(-1).h(-1), n = 20) or placebo (n = 20). Patients and clinical staff were blinded to group assignment. Transmural left ventricular biopsy specimens collected before and at the end of cardiopulmonary bypass were subjected to immunocytochemical staining against 8-iso-prostaglandin-F(2)alpha (primary measure) as an indicator for reactive oxygen species-mediated lipid peroxidation and nitrotyrosine (coprimary measure) as a marker for peroxynitrite-mediated tissue injury. Cardiomyocyte staining was quantitatively determined by using densitometry (in gray units). Global left ventricular function was measured on the basis of fractional area of contraction by using transesophageal echocardiography.
RESULTS: Patient characteristics in both groups were comparable. The change in left ventricular cardiomyocyte staining (end of cardiopulmonary bypass--before cardiopulmonary bypass) differed significantly between groups for both primary measures: 8-iso-prostaglandin-F(2)alpha, -1.8 +/- 7.5 gray units (mean +/- SD, N-acetylcysteine group) versus 5.0 +/- 4.1 gray units (placebo group; 95% confidence interval, 2.6-11.0, P =.003); nitrotyrosine, -6.4 +/- 10.0 gray units (N-acetylcysteine group) versus 9.2 +/- 8.4 gray units (placebo group; 95% confidence interval, 9.4-21.7, P <.001). Hemodynamics and clinical outcomes were comparable in both groups.
CONCLUSIONS: Reactive oxygen species scavenging with N-acetylcysteine attenuates myocardial oxidative stress in the hearts of patients subjected to cardiopulmonary bypass and cardioplegic arrest.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14666027     DOI: 10.1016/s0022-5223(03)00968-1

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  16 in total

1.  Apoptosis during CABG surgery with the use of cardiopulmonary bypass is prominent in ventricular but not in atrial myocardium.

Authors:  W T Ruifrok; B D Westenbrink; R A de Boer; I J den Hamer; M E Erasmus; H E Mungroop; A H Epema; A A Voors; D J van Veldhuisen; W H van Gilst
Journal:  Neth Heart J       Date:  2010-05       Impact factor: 2.380

2.  Adding ROS quenchers to cold K+ cardioplegia reduces superoxide emission during 2-hour global cold cardiac ischemia.

Authors:  Mohammed Aldakkak; David F Stowe; James S Heisner; Matthias L Riess; Amadou K S Camara
Journal:  J Cardiovasc Pharmacol Ther       Date:  2011-01-31       Impact factor: 2.457

Review 3.  Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants.

Authors:  Yan-Jun Xu; Paramjit S Tappia; Nirankar S Neki; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 4.  AKI associated with cardiac surgery.

Authors:  Robert H Thiele; James M Isbell; Mitchell H Rosner
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-06       Impact factor: 8.237

5.  Renal dysfunction after off-pump coronary artery bypass surgery- risk factors and preventive strategies.

Authors:  Gaurab Maitra; Ahsan Ahmed; Amitava Rudra; Ravi Wankhede; Saikat Sengupta; Tanmoy Das
Journal:  Indian J Anaesth       Date:  2009-08

Review 6.  Efficacy of N-acetylcysteine in preventing renal injury after heart surgery: a systematic review of randomized trials.

Authors:  A Selcuk Adabag; Areef Ishani; Hanna E Bloomfield; Anita K Ngo; Timothy J Wilt
Journal:  Eur Heart J       Date:  2009-03-11       Impact factor: 29.983

7.  Safflor yellow A protects neonatal rat cardiomyocytes against anoxia/reoxygenation injury in vitro.

Authors:  Jia-lin Duan; Jing-wen Wang; Yue Guan; Ying Yin; Guo Wei; Jia Cui; Dan Zhou; Yan-rong Zhu; Wei Quan; Miao-miao Xi; Ai-dong Wen
Journal:  Acta Pharmacol Sin       Date:  2013-02-11       Impact factor: 6.150

8.  Effect of intravenous administration of antioxidants alone and in combination on myocardial reperfusion injury in an experimental pig model.

Authors:  Dimitrios N Nikas; Georgios Chatziathanasiou; Anna Kotsia; Nikos Papamichael; Christoforos Thomas; Michail Papafaklis; Katerina K Naka; Nikos Kazakos; Haralampos J Milionis; Kostas Vakalis; Christos S Katsouras; Vasiliki Mpoumpa; Theodoros Vougiouklakis; Lampros Michalis
Journal:  Curr Ther Res Clin Exp       Date:  2008-10

9.  Effects of N-acetylcysteine on myocardial ischemia-reperfusion injury in bypass surgery.

Authors:  Gokcen Orhan; Nihan Yapici; Meral Yuksel; Murat Sargin; Sahin Senay; A Süha Yalçin; Zuhal Aykaç; Serap Aykut Aka
Journal:  Heart Vessels       Date:  2006-01       Impact factor: 1.814

10.  N-acetylcysteine attenuates cardiopulmonary bypass-induced lung injury in dogs.

Authors:  Xianfeng Qu; Qianyu Li; Xiaofei Wang; Xiaoping Yang; Dongguo Wang
Journal:  J Cardiothorac Surg       Date:  2013-04-22       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.